Articles

Research shows medication prescribing errors can be lowered by as much as 66% when electronic prescribing technology is used in hospitals.

The key to enhancing treatment for particular types of aggressive breast cancer may be the body’s control mechanisms for delivering zinc to cells.

Zinc plays a vital part in human health. However, too much or too little zinc can lead to cell death. In fact, mounting evidence associates zinc with a number of diseases, including cancer.

Monroe Township, NJ and Boston, MA, January 24, 2012 — A formal alliance known as The Lynx Group™ has been established between 4 privately owned medical communication companies each with a unique niche and expertise in the healthcare industry: Engage Healthcare Communications, Green Hill Healthcare Communications, Core Principle Solutions, and Center of Excellence Media.  

Monroe Township, NJ and Boston, MA, January 24, 2012 — A formal alliance known as The Lynx Group™ has been established between 4 privately owned medical communication companies each with a unique niche and expertise in the healthcare industry: Engage Healthcare Communications, Green Hill Healthcare Communications, Core Principle Solutions, and Center of Excellence Media.  
 
Read More ›

Previously, between 15% and 30% of patients treated with BRAF inhibitors developed cutaneous squamous cell carcinoma, which had to be removed surgically. Now, scientists have determined how to prevent these new cancers from occurring when patients with malignant melanoma are treated with BRAF inhibitors.

The study by researchers at The Institute of Cancer Research (ICR) was published recently in the New England Journal of Medicine.

The drug dutasteride delays both cancer progression and the start of active treatment for men diagnosed with low-risk, localized prostate cancer, according to results from a 3-year international clinical trial led by Dr Neil Fleshner, Head of the Division of Urology, University Health Network (UHN). The findings are published online in The Lancet.

A national fast track system for cancer patients that was implemented in Denmark reduced the time between a patient’s initial meeting with a healthcare provider and their first treatment by 4 weeks, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium.

The FDA recently announced the approval of Erivedge (vismodegib). This medication is available as a capsule that is taken orally once a day by adults with basal cell carcinoma (BCC) that:

A recent study shows that the administration of a short vaccination regimen with an anti-HER2 dendritic cell vaccine consisting partly of their own cells led to complete tumor destruction in nearly 20% of women with ductal carcinoma in situ (DCIS). Moreover, more than 85% of women treated appeared to develop a long-lasting immune response following vaccination, which may reduce the risk of a more invasive cancer forming in the future.

Stage III colon cancer patients experience an increased rate of survival when oxaliplatin is combined with 5-fluorouracil (5-FU) during adjuvant treatment, according to a study published in the Journal of the National Cancer Institute.